Feature

Psychiatric subspecialty is changing its name


 


Consultation-liaison psychiatrists work collaboratively with four groups of “complex medically ill” patients, Dr. Lyketsos, Dr. Levenson, and associates wrote a few years ago while advocating on behalf of the subspecialty. They treat patients with comorbid psychiatric and general medical illness; those with psychiatric illness directly tied to a primary medical condition, such as dementia or delirium; those with “complex illness behavior such as ‘somatoform’ disorders”; and those admitted to medical-surgical units after incidents such as attempted suicide. Consultation-liaison psychiatrists, who typically work in teaching hospitals, tend to provide services that are reactive – emergent or urgent (Eur J Psychiatry. 2006;20[3]:165-71).

Some think the field is limited to inpatient consultations, but it encompasses a “spectrum of physicians working at the interface between psychiatry and the other medical specialties, including many outpatient settings,” wrote Robert J. Boland, MD, academy President James R. Rundell, MD, and their associates (Psychosomatics. 2017. doi: 10.1016/j.psym.2017.11.006).

“Clinicians in consultation-liaison psychiatry face a wide breadth of conundrums and controversies in all areas of practice,” Dr. Rundell wrote in a recent newsletter. In addition to raising awareness among patients and medical-surgical colleagues, Dr. Rundell said, the academy hopes to educate other psychiatrists about the scope of consultation-liaison psychiatry.

The change will go into effect April 15.

Pages

Recommended Reading

High-intensity treadmill workouts preserved motor function in early-stage Parkinson’s
MDedge Internal Medicine
Gene silencer reduces mutant huntingtin protein in early-stage Huntington’s patients
MDedge Internal Medicine
Corynebacterium in the gut can trigger Parkinson’s disease
MDedge Internal Medicine
Low caffeine in blood could be marker of early Parkinson’s
MDedge Internal Medicine
FDA cites manufacturer of autologous stem cells for regulatory, manufacturing missteps
MDedge Internal Medicine
Mutations on LRRK2 gene modify risks for both Crohn’s and Parkinson’s
MDedge Internal Medicine
Mogamulizumab active in HTLV-1–associated myelopathy
MDedge Internal Medicine
Office-based screen predicts dementia in Parkinson’s disease
MDedge Internal Medicine
Distinguish neurogenic from nonneurogenic orthostatic hypotension
MDedge Internal Medicine
MDedge Daily News: Could gut bacteria trigger lupus?
MDedge Internal Medicine